Because alveolar fibrin is a prominent histologic feature of diffuse lung injury in baboons, we hypothesized that local abnormalities of pathways of fibrin turnover would favor fibrin deposition in the alveolar space. To test this hypothesis, procoagulant and fibrinolytic activities were characterized in serial bronchoalveolar lavage (BAL) of baboons with evolving diffuse alveolar damage (DAD) induced by exposure to 100% 02. BAL procoagulant activity, characterized mainly as the tissue factor-Factor VII complex, was markedly increased after induction of DAD. Extrinsic pathway inhibitor was likewise increased in BAL during evolving DAD but was insufficient to control coagulation. Urokinase-like fibrinolytic activity was usually detectable in baseline BAL but was undetectable after 7 d of 02. DAD BAL contained significantly increased plasminogen levels, plasmin inhibitor activity sufficient to neutralize all plasmin produced by BAL plasminogen activator found in control BAL and detectable plasminogen activator inhibitor-i. Antiplasmin activity was due, in part, to increased a2-antiplasmin. These changes correlated with quantitatively increased alveolar fibrin deposition demonstrated by histologic and morphometric analyses. Multiple abnormalities of pathways of fibrin turnover occur concurrently in the alveolar compartment of the lungs of baboons with DAD, which collectively predispose to diffuse alveolar fibrin deposition.
Introduction
Alveolar fibrin deposition is a histologic hallmark of acute alveolitis and is particularly prominent in the Adult Respiratory Distress Syndrome (ARDS)' as well as acute lung injuries in experimental animals including diffuse alveolar damage (DAD) in baboons (1) (2) (3) (4) (5) (6) . We hypothesized that abnormalities of pathways of fibrin turnover occur in alveolar fluids in asso-1. Abbreviations used in this paper: ARDS, adult respiratory distress syndromes; BAL, bronchoalveolar lavage; CHF, congestive heart failure; DAD, diffuse alveolar damage; EPI, extrinsic pathway inhibitor; FRC, functional residual capacity; NPP, normal pooled plasma; PA, plasminogen activator; PAI; plasminogen activator inhibitor; RLL, right lower lobe; TLC, total lung capacity; t-PA, tissue PA; u-PA, urokinase PA. ciation with the high grade alveolitis that characterizes evolving DAD and that these abnormalities favor alveolar fibrin deposition. To test this hypothesis, we analyzed the procoagulant and fibrinolytic activities in serial, unconcentrated bronchoalveolar lavage (BAL) fluids of baboons with evolving DAD induced by protracted exposure to 100% 02. The histology of this lung injury is characterized by extensive alveolar fibrin, hyaline membranes, varying degrees of alveolitis, and early fibrotic repair. The baboon model of DAD, induced by 100% 02, was chosen for this study as it bears strong morphologic as well as pathophysiologic resemblance to ARDS, which is likewise characterized by DAD (5, 6) .
As a result of microvascular and interstitial injury and/or local elaboration, substrates and inhibitors of coagulation and fibrinolysis may enter the alveoli, a compartment from which they are normally sequestered in the absence of inflammation. Access of such mediators is suggested by the recent demonstration that the composition of alveolar fluids in ARDS is similar to that of plasma (7) . We postulated that abnormal entry or local elaboration of these reactants establishes conditions in which local fibrin deposition is favored. Supportive evidence includes recent observations that procoagulant activity is significantly increased in BAL of bleomycin-treated marmosets (3) and patients with ARDS (8) , which, in both cases, is temporarily associated with extensive alveolar fibrin deposition.
The role of extravascular fibrin deposition in the pathophysiology of acute lung injury and DAD, in particular, is currently unclear. However, fibrin or fibrin-derived peptides are known to influence endothelial cell function (9, 10) vascular permeability (11) and inflammatory cell traffic (12) and thus may influence the inflammatory response (13). Fibrin also serves as a provisional matrix upon which fibroblasts may aggregate and secrete collagen (14) , suggesting that fibrin could influence in vivo tissue repair and scarification. Moreover, fibrinolytic and coagulation reactants may activate the complement and kinin-forming systems (15) . For these reasons, and because extensive extravascular, primarily alveolar fibrin deposition occurs in the severely injured lung, knowledge of the local abnormalities that promote alveolar fibrin deposition is essential to understanding the pathogenesis of ARDS and related forms of lung injury. In this study, we demonstrate that multiple abnormalities of pathways of fibrin turnover occur in the lower respiratory tract fluids of baboons with evolving DAD and that these abnormalities functionally predispose to the local deposition of alveolar fibrin. Methods Animals. The 17 young adult baboons (Papio cynocephalous) studied were born in captivity, had no history of respiratory disease and were free of parasites. Baseline studies, including chest x rays, pulmonary function tests and arterial blood studies were normal. The protocols used to obtain these physiologic measurements were as previously described (5) . Animals were anesthetized with ketamine and main-tained under continuous deep sedation with diazepam and muscular paralysis using pancuronium (5) . Throughout the course of these experiments, the.animals were kept on continuous mechanical ventilation in an intensive care unit-like setting. Details of the protocols for mechanical ventilation and long term management of these baboons have previously been described (5, 6) . Briefly, animals were ventilated via cuffed endotracheal tubes using a volume cycled ventilator (MA-1; Puritan-Bennett Corp., Kansas City, KS). Additional instrumentation of these animals included placement of a balloon-tipped pulmonary artery catheter, an arterial catheter, and urinary bladder catheter. Trended measurements included electrocardiographic monitoring, determination of systemic and pulmonary vascular pressures, cardiac output determinations and arterial blood gas studies. In addition, daily chest x rays were followed and serial pulmonary function testing including determination of functional residual capacity (FRC), diffusing capacity (DLCO) and total lung capacity (TLC) were performed.
After collection ofbaseline data on the first day ofeach experiment, DAD was induced by exposure to 100% oxygen (n = 10 animals). Alternatively, control baboons were mechanically ventilated while receiving 21% oxygen (n = 7 animals). To prevent bronchopulmonary infection, animals were given ampicillin and polymyxin. Animals received a prophylactic antacid (Maalox; William H. Rorer, Inc., Fort Washington, PA) every 4 h. Fluids were administered intravenously on the basis ofblood chemistries, urinary output, and hemodynamic measurements. A fiberoptic bronchoscope (pediatric model; Olympus Corp., Irving, TX) was used to perform BAL, which consisted of the instillation of 90 ml of saline into a single lobe. Baboons exposed to 100% 02 or controls ventilated with 21% 02 were instilled with 90 ml of saline. The recovered fluid was centrifuged at 2,500 g at 4VC for 10 min. The pellet was used to determine total and differential white cell counts, while the supernatant was centrifuged at 12,000 g for 15 min and the supernatant frozen at -70'C until used. In preliminary experiments, we found that 1251 radiolabeled Factor Xa or plasminogen were not altered by the lavage processing procedure. The physical form of these proteins, when added to BAL alone or to BAL supplemented with I X 106 human neutrophils/ml and then processed as described above, was virtually identical. Plasminogen remained in the 90,000 M, form in saline, as well as baseline or DAD BAL with or without BAL processing. Factor Xa migrated at 53,000 in saline and in baseline BAL but was, in part, complexed at 120,000 Mr in DAD BAL, with or without BAL processing. DAD was induced by exposing baboons to 100% inspired oxygen for 5-9 d. The infusion ofdopamine was used to treat severe systemic hypotension which was associated with severe, edematous lung injury necessitating the use of positive end expiratory pressure (PEEP) in three of these animals. BAL was obtained before the initiation of 100% oxygen and at either 5, 7, and in some cases, 9 d after exposure.
Seven control animals were mechanically ventilated with 21% oxygen for 5-1 1 d. These animals were maintained under the same conditions as those described above. BAL was obtained at day 0, 7, and 11 of control mechanical ventilation as described above.
Histologic and morphometric studies. Autopsy was performed immediately after the death or elective sacrifice of each animal. Lungs were perfused for 15 min with phosphate-buffered 4% formaldehyde-1% glutaraldehyde fixative (4CF-IG) at 28 cm H20 pressure using a rolling pump (16) .
Specimens were prepared for light microscopy and transmission electron microscopy as previously described (5) . Lung blocks were obtained from the right upper and right middle lobes (one each), studied by routine light microscopy and used for correlation with microbiologic results. The right lower lobe (RLL) was dedicated entirely for pathologic and morphometric studies. After weighing and intrabronchial fixation with phosphate-buffered 4% paraformaldehyde at 20 cm H20 constant airway pressure for 48 h (17), the RLL lung volume was determined by volume displacement and transverse 1.0-cm sections were taken at three levels through each lobe (18) . The entire surface of each transverse slice of the RLL was totally sampled and blocked for light microscopic studies with an average of 14 blocks being examined.
Determination of both the extent and severity of DAD (either exudative, reparative, or mixed patterns) and pneumonias (graded histologically as organizing, mild, moderate, or severe) was accomplished. Electron microscopy specimens were obtained from 5 or more representative areas ofthe usual 14 light microscopic sample sites. 50 blocks were fixed in Zetterqvist's osmium fixative of which 20 were then embedded and thick sectioned. Six blocks were then thin sectioned and stained with Reynolds' lead citrate and uranyl acetate. The presence of fibrin within the alveolar space was confirmed by its characteristic periodicity on electron microscopy (19) . Volume density determinations of the presence of fibrin within the alveolar space were accomplished on specimens of the 100% oxygen treated animals and were compared with a group ofnonventilated healthy baboon controls using established techniques (20). Three animals were randomly selected from each group for analysis.
Coagulation assays. Single-stage coagulation assays in which BAL was exposed to either normal pooled human plasma or human plasmas deficient in Factors VII, VIII, or X were performed as previously described (3, 8) . All assays were performed in duplicate using the same lot of each deficient plasma to assay all BAL samples. Extrinsic pathway inhibitor (EPI) activity was measured in a three-stage coagulation assay, as previously described (21) . A standard curve was constructed from pooled normal human plasma and showed a direct linear relationship between the logarithm of the clotting time and the logarithm of the plasma containing EPI between 0.2-8%, assuming 100 ng EPI/ml plasma (21) .
Amidolytic assay ofFactor Xa. Conversion of Factor X to Xa by baboon BAL was determined by an amidolytic assay performed as previously described, with slight modifications (8) . In this assay, 45 M1
of BAL was incubated with 30 Mll of0.15 M NaCl, 0.02 M Tris, pH 7.4 (TBS), and 15 Ml human Factor X (10 U/ml). This mixture was incubated at 370C for up to 30 min. 75-;il aliquots were added to a spectrophotometer cuvette containing 25 ul of 4 mM benzoylisoleucyl-glutamyl-glycyl-arginine-p-nitroanilide (S2222; Kabi Group, Inc., Greenwich, CT) and 200 Ml of 50 mM Tris, 175 mM NaCl, and 7.5 mM EDTA, pH 8.4. The initial rate of increase in absorbance at 405 nm was determined on a response spectrophotometer (Gilford Instruments, Inc., Oberlin, OH). The picomoles ofFactor X hydrolyzed per minute per milliliter of BAL was calculated based on the initial rate of increase of absorbance generated by human Factor Xa standards as previously described (3).
Proteolytic cleavage "25-labeled human Factor X. Factor X was labeled with Na 125I as previously described (8) . Baboon BAL was incubated at 37°C with a mixture of radiolabeled and unlabeled human Factor X (5 Mg/ml) in polypropylene tubes for 30 min. Aliquots were removed and subjected to nonreduced SDS polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiographic development of the dried gel as we have previously described (3, 8) .
Neutralization ofBAL Factor X activating activity by antibodies to Factor VII and tissuefactor. Equal volumes ofbaboon BAL and rabbit antibodies (IgG fraction) to Factor VII (50 Mg/ml), tissue factor (100 ,Mg/ml), or nonimmune IgG were incubated for 1 h at 37°C after which BAL Factor X activating activity was determined in the Factor Xa amidolytic assay. Characterization of the neutralizing antibody to human Factor VII has been previously described (22) . Antibody to bovine tissue factor, which cross-reacts with human tissue factor (23, 24) , was generously provided by Dr. Ronald Bach (Yale University, New Haven, CT).
Fibrin plate assay ofBALfibrinolytic activity. Plasminogen activator (PA) activity and plasminogen independent fibrinolytic activity of baboon BAL was assayed in '25I-fibrin plates as previously described (25, 26) . The sensitivity ofthe assay performed as described was 0.0001 IU/ml based on urokinase standards (American Diagnostics, Inc., Greenwich, CT). PA Characterization ofPA and PA inhibitory activity in baboon BAL. PA of baboon BAL was also characterized by fibrin gel autography, as described by Levin and colleagues (27) . Briefly, BAL samples or standards were subjected to SDS-PAGE using 10% acrylamide resolving gels (3). The gel was then soaked in 0.1 M sodium phosphate pH 7.2 with 2.5% Triton X-100, blotted dry and placed on top of a freshly prepared fibrin indicator gel. The indicator gel was allowed to develop at room temperature in a moist chamber, and the resulting clear lysis zones were photographed. Reverse fibrin gel autography was performed as previously described (28) . Samples were subjected to SDS-PAGE, the gel soaked in Triton X-I00 and then placed over a fibrinagar indicator plate supplemented with 0.075 IU/ml ofurokinase (final concentration). Regions of the gel containing inhibitor were revealed by the formation of opaque, lysis-resistant zones in the clear, lysed indicator gel.
Antiplasmin activity. Alternatively, antiplasmin activity was measured by a decrease in the initial rate of plasmin-mediated hydrolysis of the chromogenic substrate H-D-Val-Leu-Lys-p-nitroanilide (S-2251; KABI Group, Inc.) (29) . Briefly, 50 Ml of plasmin (10 Ag/ml in TBS) was mixed with 50 Ml of normal saline or BAL samples, incubated at 37°C for 10 min and then added to prewarmed spectrophotometer cuvettes containing 25 Ml of 3.5 mM S-2251 and 175 Mul of TBS. Initial rates of cleavage of the substrate were assessed by the change in absorbance at 405 nm using a spectrophotometer (DU 30; Beckman Instruments, Inc., Fullerton, CA) and were linear for at least 5 min. The rates were converted to micrograms per milliliter of plasmin based upon the amidolytic activity generated by plasmin standards. Residual plasmin activity of the plasmin-BAL samples was expressed as percent inhibition relative to the plasmin standard mixed with saline. Expression of amidolytic activity by plasmin was unaffected by addition ofup to 2 mg/ml asolectin (American Lecithin Co., Woodside, NY), which represented 100 times the phospholipid content we previously reported in BAL of patients with ARDS (8) . Addition of up to 10 mg/ml of bovine serum albumin likewise did not interfere with plasmin-mediated amidolytic activity.
Goat antibody to human a2-antiplasmin (a2AP) and control goat IgG were purchased from American Diagnostics and bound to Affigel-10 beads (Bio-Rad Laboratories, Richmond, CA), according to the manufacturer's instructions at a ratio of 5 mg IgG/ml of resin. a2AP (American Diagnostics) was shown to inhibit plasmin, when it was diluted to 10 ug/ml in TBS and then mixed for 10 min at 37°C with 10 Mg/ml plasmin. This inhibitory capacity was removed if a2AP was incubated for I h at 37°C with antibody to a2AP bound to Affigel-10 but was unchanged after adsorption with control beads. BAL samples were incubated with either anti-a2AP or control beads 1:1 (vol/vol) for 1 h at room temperature, and the beads were then sedimented by a flash spin using a Beckman microfuge. Remaining antiplasmin activity was measured in two assays. To 60 Ml ofsupernatant was added 60 Ml of plasmin standard (6 ,g/ml) for 10 min at 37°C and the plasmin-mediated amidolytic activity was determined. Alternatively, the supernatants were mixed 1:1 with a plasmin standard (1.25 ug/ml in normal saline) for 30 min at 37°C and plasmin-mediated release of radiolabeled fibrin was measured in the '25I fibrin plate assay.
Radioimmunoassays. Double antibody competitive equilibrium radioimmunoassays were modified from those previously reported for human plasminogen and a2AP (29) . Proteins were radioiodinated by the dilute chloramine T method (30) to specific activities of 1.7-6.6 uCi/Mug. To 250 Ml of labeled protein (0.5 nM) was added 250 Al of competing human protein (for standard curve) or bronchoalveolar fluid (diluted 1:4) and 250 Ml of antibody diluted to give -30% binding ofthe iodinated ligand. After incubation at 4VC for 16-20 h, 500 M1 of goat anti-rabbit (Pel-Freez Corp., Rogers, AR) IgG was added and incubated at 4VC for 6 h. The immunoprecipitates were collected by centrifugation at 2,000 g for 15 min, and 500 Ml of supernatant was counted in a gamma counter. In control studies, semilogarithmic graphs of the inhibition of '251I-protein binding to its specific antibody seen by normal baboon plasma was parallel to the competition curves observed for human plasma permitting an estimate of these proteins present in biological fluids. The buffer used for the assay contained 50 mM Tris/HCl (pH 8.0), 25 mM NaCl, 10 mM benzamidine, 1 mM PMSF, 5 U/ml aprotinin, 0.75% normal rabbit serum, and 0.02% NaN3. Plasminogen was purified from human plasma by the method of Deutsch and Mertz (31) and human a2AP was bought from American Diagnostica. Rabbit antibodies to human plasminogen and a2AP were generously provided by Dr. Edward F. Plow and Dr. Lindsey A. Miles (Research Institute of Scripps Clinic, La Jolla, CA).
Characterization oftheform ofplasminogen-related antigen in baboon BAL. BAL plasminogen related antigen was adsorbed by addition of 20 Ml oflysine-Sepharose 4B (coupled by CNBr; 32) to 1 ml of BAL sample and mixed by rotation at room temperature for 1 h. The beads were collected by centrifugation for 30 s using a Beckman Microfuge and washed once in normal saline. Plasminogen-related antigen was eluted by boiling the antibody-Sepharose beads for 4 min in the 2% SDS, 1% glycerol, 62.5 mM Tris-HCI, pH 6.8. Supernatants were applied to 4% acrylamide stacking gels and run on 10% acrylamide resolving gels by the method ofLaemmli (33) . Electrophoretic transfer to nitrocellulose was performed according to Towbin et al. (34) using a Bio-Rad transfer cell with a recirculating water bath (4°C) at 60 V for 90 min. The nitrocellulose paper was "blocked" by incubation with 0.5 M NaCl, 0.01 M Tris, pH 7.5, 3% gelatin for 30 min at room temperature, incubated with a 1:200 dilution of rabbit anti-human plasminogen overnight at 4°C, and reacted with 0.1 Mg/ml 1251 goat anti-rabbit IgG, radiolabeled according to the method of Fair et al. (30) , for 3 min at ambient temperature. Plasminogen derivatives were localized by autoradiography, and the molecular weights of plasminogen species were determined by the relative migration of transferred prestained standards (Bio-Rad Laboratories).
Human pleural fluids. Pleural fluids were collected by standard thoracentesis technique from hospitalized patients in order to examine the specificity of abnormalities of fibrin turnover observed in BAL. Pleural fluids were harvested from patients with congestive heart failure (CHF, n = 6), patients with pneumonia and parapneumonic effusions (n = 4), empyema (n = 3), and patients with carcinoma of the lung and associated pleural effusions (n = 16), and were immediately collected in polypropylene tubes containing 3.8% sodium citrate in a ratio of 9:1, pleural fluid/citrate. The fluids were immediately centrifuged at 400 g for 10 min, after which the pleural fluid total white cell and differential counts and protein content were determined (3, 8) . The cell-free pleural fluids were then immediately frozen at -70°C until further processing was completed. Pleural fluids were harvested for clinical indications, and the collection of these fluids for this study was approved by the Human Subjects (Fig. 2 B) . Super-mosets with bleomycin-induced lung injury (3, 8) and sugkeumonitis characterized by gested that tissue factor-Factor VII complex was the major PMNs) in respiratory bron-procoagulant activity present in baboon BAL. Further, this )t shown). activity was sedimentable by ultracentrifugation at 100,000 g Pneumonia, and DAD was for 2 hat 40C, suggesting the presence ofa tissue factor moiety. animal (Table I) . Analysis The Factor X activating activity was completely neutralized in Fise presentation in 7 of 10 the presence of the antibody to Factor VII (Table IV) . The antibody to tissue factor was also effective in inhibiting the Factor X activating activity. Therefore, tissue factor associated with Factor VII accounts for the major procoagulant activity QL PROTEINS present in baboon BAL.
As shown in Fig. 3 elevated following DAD, while a transient increase in Factor Xa generation was noted for 21% 02 controls (Fig. 4) . Injury with 100% 02 indicated a clear inverse relationship between Factor X activation and the presence of EPI. No correlation was evident between these parameters during the period of control ventilation, although modest elevations were noted, presumably as a result of focal bronchopneumonia.
In preliminary experiments, we found that the addition of baboon plasma, or lysed or live human neutrophils to BAL shortened the recalcification times of BAL in normal pooled human plasma but failed to increase the Factor X activating activity of BAL. No procoagulant activity was observed in the neutrophil preparations and extremely small amounts were found in baboon plasma by recalcification, but not amidolytic assays. These data indicate that the influx of neutrophils into the lung was not responsible for the observed increase in procoagulant activity.
Characterization and quantitation ofthe fibrinolytic activity present in baboon BAL. Fibrinolytic activity was usually but not invariably detectable in unconcentrated baseline BAL (Fig. 5) . In baboons ventilated with 21% 02, fibrinolytic activity was either stable or rose somewhat after several days of mechanical ventilation, but was not significantly changed from baseline levels. In baboons with 100% 02 injury, the BAL fibrinolytic activity was reduced at day 5 and undetectable by days 7 and 9. In the 100% oxygen-treated group, one animal (No. 4081) developed only mild lung injury. In this animal fibrinolytic activity was detectable at all time points after the administration of 100% 02. Thus, depressed fibrinolytic activity present in baboon BAL appeared to be associated with the induction of DAD. The addition of lysed or live human neutrophils increased the total fibrinolytic activity found in baseline baboon BAL. Addition oflysed or live neutrophils to BAL ofbaboons with evolving DAD that lacked fibrinolytic activity did not generate detectable fibrinolytic activity and the addition of baboon plasma to BAL inhibited BAL fibrinolytic activity. Because fibrinolysis is initiated by specific plasminogen activators (PA), we characterized the components of the fibrinolytic system in BAL. The fibrinolytic activity present in baboon BAL was mainly plasminogen dependent. Plasminogen independent fibrinolytic activity was not detectable in unconcentrated BAL at any time point by the fibrin plate assay (data not shown). Further, PA activity could be neutralized by an antibody to urokinase but not by nonimmune IgG controls or an antibody specific for t-PA in the 125I fibrin plate assay (Table V) . When the molecular weight of the PA was investigated by fibrin gel autography, the major zone of fibrinolytic activity present in baboon BAL was found to comigrate with urokinase standards (Fig. 6 a) and be neutralized by an antibody to urokinase (Fig. 6 b) . Additional higher molecular weight zones of fibrinolysis were identified at Mr 85,000 and 110,000 and were most prominent in DAD BAL. Lytic zones were undetectable or grossly attenuated in baseline baboon BAL (n = 9 samples) when plasminogen was deleted from the indicator plates. By contrast, prominent zones offibrinolysis at Mr 110,000 but not 85,000 were found in BAL samples from baboons with DAD when plasminogen was deleted (data not shown). The 85,000 Mr zone of fibrinolysis was not inhibited in the presence of either of our antibodies to u-PA or t-PA. These experiments indicate that urokinase-like fibrinolytic activity was present in baboon BAL and that plasminogen independent fibrinolytic activity could also be detected in BAL of baboons with evolving DAD using fibrin gel enzymography.
Because the BAL from baboons with DAD demonstrated lytic zones at higher molecular weight and because these BAL samples had no detectable fibrinolytic activity when studied by the fibrin plate assay, we reasoned that specific inhibitor(s) of PA or plasmin were likely to be present. Determination of BAL PA inhibitors (PAI) was monitored by reverse fibrin autography. Baseline BAL harvested before lung injury contained no detectable PAI activity, whereas these samples contained detectable u-PA activity by the fibrin plate assay and fibrin gel autography. However, after induction of lung injury leading to DAD, lysis-resistant zones were detected at 45,000 Mr in some (three of six) DAD BAL samples, indicating the presence of PAL. In separate experiments, we found that this zone of PAI migrated near that of Hep G2 cells, which are known to produce PAI-1 (35) and this zone could be inhibited by an antibody to PAI-l (Fig. 7) .
The absence of detectable fibrinolytic activity in BAL of baboons with DAD in the fibrin plate assay was not associated with local insufficiency of plasminogen substrate in these fluids. Increased levels ofplasminogen were detectable in BAL of baboons with DAD or pneumonitis compared to baseline BAL (P = 0.04) (Fig. 8) . Injury with 100% 02 led to a progressive increase in plasminogen to very high levels over the course of 9 d (Fig. 8) . Ventilated 21% 02 controls showed a modest increase with time, but the levels were well below those measured in baboons with DAD.
We next investigated whether the plasminogen had been cleaved within the BAL. Plasminogen was isolated from BAL using lysine-agarose absorption and the plasminogen-related proteins separated by SDS-PAGE, transferred to nitrocellulose, and localized by immunoblotting (Fig. 9) . The major plasminogen species in control or DAD BAL was the Glu-lplasminogen with an Mr 90,000. Activation of the native pro- The box plot format is described in Fig. 1 . Confidence limits are described in the text.
pothesized that baseline fibrinolytic activity was inhibited by inhibitor(s) derived from plasma that had leaked into the alveolar space. The presence of inhibitors of fibrinolysis was initially suggested on the original '251-fibrin plates. To determine whether plasmin inhibition was responsible for the depressed BAL fibrinolytic activity after lung injury, we incubated these BAL samples with purified plasmin at a concentration predetermined to equal or to exceed the highest levels generated by the PA found in control baboon BAL. As shown in Table VI , fibrinolytic activity of the plasmin standards at 2.5 or 5 ug/ml was completely inhibited by the addition of BAL lacking fibrinolytic activity from baboons with DAD, indicating the presence of an active inhibitor of plasmin. Plasmin inhibitory activity was also found to increase, by amido- lytic assay, in serial BAL during the evolution of DAD (data not shown). Baseline BAL contained little antiplasmin activity; mean fibrinolytic activity generated by 2.5 lsg/ml plasmin mixed with baseline baboon BAL = 0.2864 IU/ml (n = 4 samples) vs 0.3046 IU/ml generated by the plasmin standard mixed with normal saline in the fibrin plate assay. Whereas plasmin inhibitory activity was observed upon injury, little antiplasmin activity was found in baseline BAL or that of control 21% 02 baboons by either fibrinolytic or amidolytic assays.
In order to determine whether a2AP contributed to the depressed fibrinolytic activity in BAL of baboons with evolving DAD, we adsorbed these BAL samples with goat antibody to a2AP or control goat IgG. The adsorbed samples were then tested for their ability to neutralize a 1.25-,ug plasmin standard in the fibrin plate assay (Table VII) . The-samples (n = 5) chosen for these experiments contained no detectable fibrinolytic activity and were obtained from baboons with acute lung injury and evolving DAD. As shown in Table VII ples obtained during development of DAD, which lacked fibrinolytic activity, contained significant amounts of antiplasmin activity.
To examine the specificity of the abnormalities of fibrin turnover we detected in BAL of baboons with DAD, we measured the procoagulant and fibrinolytic activities present in human pleural fluids which served as non-BAL controls. All pleural fluids from patients with CHF were transudative, whereas those from patients with pneumonia, empyema or carcinoma of the lung fulfilled criteria for exudates (36 (Table VIII) . Exudative pleural effusions rarely (4 of 23 exudates) contained detectable plasminogen-dependent fibrinolytic activity in the 1251-fibrin plate assay, whereas this fibrinolytic activity was detectable in five of the six pleural fluid samples from patients with CHF. Shorter recalcification times, indicating increased procoagulant activity, were detectable in pleural fluids of patients with pneumonia or lung cancer compared to patients with congestive heart failure which did not differ from the recalcification times in normal pooled plasma ofpleural fluids from patients with empyema. These data indicate that similar trends of both procoagulant and fibrinolytic activities occur in exudative pleural fluids and DAD BAL. Increased procoagulant activity in the setting of high-grade pleural inflammation (empyema) does not invariably occur (Table VIII) , whereas it is consistently observed in BAL of all baboons during evolving DAD (Fig. 3) .
Discussion
Tissue fibrin deposition represents the net effect of procoagulant mechanisms which favor fibrin formation and fibrinolysis which favors its dissolution. The balance between these processes may therefore be inferred to control fibrin deposition in the alveolar space, such as occurs in the setting of acute lung injury. Extravascular fibrin deposition, chiefly within the alveoli characterizes the exudative phase of DAD in patients with the adult respiratory distress syndrome (ARDS) (1), and may occur in association with the high grade alveolitis associated with the interstitial lung diseases (2) . We chose to study the baboon model, because extensive alveolar fibrin formation uniformly accompanies the lesion of DAD'in baboons with induced ARDS (5), because of phylogenetic proximity' of the model to humans and because of availability of immunologic reagents which cross-react with baboon proteins. Animals were studied under conditions approximating those currently used in the care of patients with ARDS including invasive instrumentation and mechanical ventilation. We studied a model of DAD, induced by protracted exposure to hyperoxia, which is germane to clinical circumstances associated with ARDS in'humans (37) . Superinfection, as observed in this Lung injury induced by 100% 02 in baboons was associated with an increase in BAL procoagulant activity. Recalcification times in deficient plasmas, ultracentrifugation, and antibody neutralization studies indicated that the procoagulant activity was attributable to the expression of the extrinsic activation complex; that is, tissue factor associated with Factor VII. Of interest was the apparent inverse relationship between the level of EPI and Factor Xa generation after oxygen injury. With the 100% oxygen-induced injury, there was a gradual increase in EPI with a concomitant decrease in Factor Xa production. Because the lung is relatively rich in the components of the extrinsic pathway; tissue factor and Factor VII (38) , the potential for the EPI to control initiation of coagulation may be diminished, which results in a net expression of procoagulant activity. The increase in lower respiratory tract procoagulant activity in baboons with DAD is similar to that which we and others have previously described in the BAL of human subjects and marmosets (3, 8, 38, 39) . The observation of modestly augmented procoagulant activity in BAL of some ofthe baboons mechanically ventilated with 21% oxygen is not surprising, in as much as these animals often developed superinfection with histologic evidence of purulent pneumonitis.
Fibrinolytic activity present in baboon BAL was found to be immunologically cross-reactive with antibodies to human urokinase. It has previously been reported that urokinase-like fibrinolytic activity is readily detectable in BAL of normal human subjects (39) . We found that a similar, if not identical, PA was usually present in baboon BAL under normal circumstances. In the absence of clinically apparent lung disease or superimposed pneumonitis, BAL contained relatively large amounts of fibrinolytic activity and at that same time had relatively small amounts of procoagulant activity. The net effect of these combined processes would be to favor fibrin dissolution. This baseline procoagulant-fibrinolytic balance in alveolar lining fluids probably explains the absence of fibrin within the alveoli under normal circumstances. Previously, it has been found that fibrinogen is not a resident protein of the alveolar lining fluids and that fibrin is not normally found at extravascular or intravascular sites within the normal lung (1, 40). Our morphometric and histologic findings support these observations as well as the notion that the local balance between procoagulant activity and fibrinolysis in alveolar fluids is a crucial determinant ofalveolar fibrin deposition within the lung.
Following the induction of DAD, abnormalities of the local procoagulant-fibrinolytic balance were apparent. The pattern observed in BAL was that of augmented procoagulant activity in association with depressed fibrinolytic activity. These disturbances would be expected to additively favor tissue fibrin deposition. We found that this local disruption ofthe procoagulant-fibrinolytic balance was temporally associated with alveolar fibrin formation both histologically and morphometrically in baboons with DAD. These observations are unlikely to be solely attributable to the contamination of DAD BAL by plasma-derived or leukocyte proteases as: (a) the addition of baboon plasma, and to a lesser extent, lysed or live neutrophils could shorten the recalcification times of BAL in plasma but did not generate increased Factor X-activating activity and (b) the addition of lysed or live neutrophils, in quantities comparable to those originally harvested, failed to generate increased fibrinolytic activity in DAD BAL. Similar trends of procoagulant and fibrinolytic activities occurred in association with exudative pleural disease, indicating that locally disordered fibrin turnover is not specific to the alveolar space in DAD but may also accompany exudative processes in the pleural compartment. The lack of consistently increased procoagulant activity in empyema fluids is consistent with previous reports (41) and indicates that high-grade inflammation in the pleural space is not invariably associated with increased local procoagulant activity, such as consistently occurs in BAL during evolving DAD.
In addition to PA, low levels of substrate plasminogen are present in the native form in the normal lung. It is probable that PAI keeps the system regulated under normal homeostasis. Upon injury, plasminogen is increased, but we paradoxically measured a decrease in fibrinolysis. Depressed fibrinolytic activity present in BAL obtained from animals with evolving DAD was contingent upon antiplasmin activity in these BAL samples, which was potent enough to inhibit expression of levels of fibrinolytic activity generated by levels of PA present in control BAL. Baseline baboon BAL samples or those of control baboons ventilated with 21% 02 contained little or no antiplasmin activity, while BAL samples from baboons with evolving DAD contained large amounts of antiplasmin activity. These observations suggest that inhibition of plasmin by constituent(s) of BAL from baboons with evolving DAD is in large part responsible for the depressed fibrinolytic activity found in these samples. Inhibition of plasmin was, in part, due to a2 antiplasmin, which likely entered the alveolar space as a result of microvascular injury, but could be locally elaborated as well. This observation does not preclude the possibility that other inhibitors, notably PAl-1 or PAI-2, could also depress fibrinolytic activity in the alveolar lining fluids in the setting of lung injury. Indeed, we found PAI activity, due to PAI-l, in BAL of baboons after, but not before induction of DAD, suggesting that a dual mechanism of inhibition (one for PA and one for plasmin) may account for the local depression of fibrinolytic activity in the injured primate lung.
The virtually universal occurrence of alveolar fibrin in the inflamed alveolar compartment suggests the possibility that tissue fibrin deposition and the procoagulant-fibrinolytic balance in alveolar fluids may be of importance in the pathogenesis of acute lung injury and repair. In a process analogous to that which occurs during normal wound healing (42) , it is likely that intraalveolar fibrin provides an abnormal matrix for the subsequent deposition of fibrous tissue. It has previously been shown that fibrin deposits occur at sites of pulmonary scar formation (43, 44) . In addition, fibrin and fibronectin form a suitable matrix for attraction of fibroblasts with resultant secretion of collagen in vitro (14) . The relationship between the observed local abnormalities of pathways of fibrin turnover and fibrin deposition in the pathogenesis of DAD and accelerated pulmonary fibrosis remains to be established and is contingent upon the results of specific interventions that are designed to interrupt these pathways and arrest alveolar fibrin deposition in DAD. Our data provide the rationale for such interventions and suggest the feasibility of strategies which target abnormalities of either coagulation or fibrinolytic pathways in DAD. We conclude that locally disordered fibrin turnover, based upon multiple, concurrent, prothrombotic abnormalities of pathways of both coagulation and fibrinolysis, accompanies increased alveolar fibrin deposition in the lungs of baboons with DAD.
